In addition to MV4–11/MOLM-14, significant elevation of FBP1 and induction of blast differentiation could be observed in 1,25VD3 treatment of HL60, a human acute promyelocytic leukemia (APL) cell line (Supple. Here, FBP1 is linked to acute promyelocytic leukemia.